pSivida (PSDV) Says Medidur Inserter Utilization Study with Smaller-Diameter Needle Met Primary Endpoint
Tweet Send to a Friend
pSivida Corp. (Nasdaq: PSDV) announced that its utilization study of its new, proprietary 27-gauge inserter for Medidur for posterior uveitis ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
